Bonus BioGroup
Press Room

Press Releases 2015

Press Releases 2015 (9)

Bonus BioGroup Enters Into an Exclusive Agreement for the Use of Engineered Nanoparticle Technology to Enhance Bone Regeneration

Bonus BioGroup to Hold Pre-IND Meeting with FDA Focused on Proposed Clinical Trial in the US

Bonus BioGroup Raises Investment of 5.2 Million NIS through Private Offering at 60 Cents per Share

Bonus BioGroup Announces Chief Scientist Support of R&D Program Totalling 6.4 Million NIS

Bonus BioGroup Receives EU Grant for Joint Development of New Method for Graft Tracking In Vivo

 Bonus BioGroup Announces Agreement to Develop Innovative Biological Components

The agreement allows Bonus to receive FDA approval for innovative biological components which will be integrated into its manufactured transplants. These will be submitted to the FDA at no cost for Bonus. 

Bonus Therapeutics Selected Amongst 100 Most Promising Innovative Technology Companies in Europe

Bonus BioGroup Announces Completion of Recruitment of 20 Patients for Clinical Trial to Repair Human Facial Bone Deficiency 

Bonus BioGroup Announces Receipt of European GMP and International ISO-9001 Certification


Press Release, Announcements publication and more

Bonus BioGroup



Terms of UsePrivacy Policy | Login        

© 2021 Bonus BioGroup Ltd. All Rights Reserved. Designed By Netron Israel Ltd.